Dose escalation and pharmacodynamic study of intravenous adminstration of Reolysin, a live replication competent RNA virus in patients with advanced solid tumors

被引：0
|
作者：
Ghalib, M. H.
Desai, K. K.
Gollamudi, R.
Chaudhary, I.
Einstein, M.
Coffey, M.
Mettinger, K.
Mani, S.
Goel, S.
机构：
[1] Montefiore Med Ctr, Bronx, NY 10467 USA
[2] Oncolytics Biotech Inc, Calgary, AB, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3583
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Intravenous administration of Reolysin®, a live replication competent RNA virus is safe in patients with advanced solid tumors
    Radharani Gollamudi
    Mohammad H. Ghalib
    Kavita K. Desai
    Imran Chaudhary
    Benny Wong
    Mark Einstein
    Matthew Coffey
    George M. Gill
    Karl Mettinger
    John M. Mariadason
    Sridhar Mani
    Sanjay Goel
    Investigational New Drugs, 2010, 28 : 641 - 649
  • [2] Intravenous administration of ReolysinA®, a live replication competent RNA virus is safe in patients with advanced solid tumors
    Gollamudi, Radharani
    Ghalib, Mohammad H.
    Desai, Kavita K.
    Chaudhary, Imran
    Wong, Benny
    Einstein, Mark
    Coffey, Matthew
    Gill, George M.
    Mettinger, Karl
    Mariadason, John M.
    Mani, Sridhar
    Goel, Sanjay
    INVESTIGATIONAL NEW DRUGS, 2010, 28 (05) : 641 - 649
  • [3] Pharmacodynamic and safety study of reolysin in patients with advanced solid tumors
    Gollamudi, R.
    Desai, K.
    Chaudhary, I.
    Ghalib, M. H.
    Wong, B.
    Einstein, M.
    Coffey, M.
    Gill, G.
    Mani, S.
    Goel, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] A phase I dose escalation and pharmacodynamic study of weekly administered AlbuleukinTM in patients with advanced solid tumors.
    Agarwala, SS
    Bukowski, RM
    Kirkwood, J
    Weiss, P
    Olencki, T
    Grzegorewski, KJ
    Melder, R
    Fox, RA
    Herpst, JM
    Gallant, G
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6230S - 6231S
  • [5] A dose escalation study of weekly docetaxel in patients with advanced solid tumors
    Kouroussis, C
    Agelaki, S
    Mavroudis, D
    Souglakos, J
    Kakolyris, S
    Kalbakis, K
    Vardakis, N
    Reppa, D
    Hatzidaki, D
    Samonis, G
    Georgoulias, V
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2000, 46 (06) : 488 - 492
  • [6] A dose escalation study of weekly docetaxel in patients with advanced solid tumors
    Ch. Kouroussis
    S. Agelaki
    D. Mavroudis
    J. Souglakos
    S. Kakolyris
    K. Kalbakis
    N. Vardakis
    D. Reppa
    D. Hatzidaki
    G. Samonis
    V. Georgoulias
    Cancer Chemotherapy and Pharmacology, 2000, 46 : 488 - 492
  • [7] Dose escalation of tinostamustine in patients with advanced solid tumors
    Mita, Alain
    Loeffler, Markus
    Bui, Nam
    Mehrling, Thomas
    Rimmel, Bobbie J.
    Natale, Ronald B.
    Kummar, Shivaani
    CANCER RESEARCH, 2019, 79 (13)
  • [8] Phase I Dose-Escalation Study of Intravenous Aflibercept in Combination with Docetaxel in Patients with Advanced Solid Tumors
    Isambert, Nicolas
    Freyer, Gilles
    Zanetta, Sylvie
    You, Benoit
    Fumoleau, Pierre
    Falandry, Claire
    Favier, Laure
    Assadourian, Sylvie
    Soussan-Lazard, Karen
    Ziti-Ljajic, Samira
    Trillet-Lenoir, Veronique
    CLINICAL CANCER RESEARCH, 2012, 18 (06) : 1743 - 1750
  • [9] A dose-escalation study of oxaliplatin and vinorelbine in patients with advanced solid tumors'
    Kakolyris
    ONCOLOGY, 2006, 71 (3-4) : 203 - 203
  • [10] A dose-escalation study of oxaliplatin and vinorelbine in patients with advanced solid tumors
    Kakolyris, S
    Kouroussis, C
    Koukourakis, M
    Marvroudis, D
    Malas, K
    Vardakis, N
    Bozionelou, V
    Kalbakis, K
    Georgoulias, V
    ONCOLOGY, 2002, 63 (03) : 213 - 218
12345